IRIS
GOBBI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.021
AS - Asia 1.560
EU - Europa 1.195
SA - Sud America 153
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 8
Totale 5.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.984
CN - Cina 771
SG - Singapore 352
IE - Irlanda 276
FI - Finlandia 163
HK - Hong Kong 163
UA - Ucraina 149
RU - Federazione Russa 147
DE - Germania 133
VN - Vietnam 125
BR - Brasile 109
SE - Svezia 81
FR - Francia 61
ZA - Sudafrica 59
GB - Regno Unito 57
IT - Italia 54
IN - India 43
CA - Canada 20
AR - Argentina 19
BE - Belgio 14
TR - Turchia 13
BD - Bangladesh 12
PL - Polonia 12
CZ - Repubblica Ceca 10
JP - Giappone 10
MA - Marocco 8
MX - Messico 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
EC - Ecuador 7
NL - Olanda 7
AU - Australia 6
EU - Europa 6
IQ - Iraq 6
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
PH - Filippine 5
AT - Austria 4
EG - Egitto 4
ET - Etiopia 4
KE - Kenya 4
LB - Libano 4
MY - Malesia 4
VE - Venezuela 4
ES - Italia 3
GE - Georgia 3
GR - Grecia 3
ID - Indonesia 3
JO - Giordania 3
MK - Macedonia 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
JM - Giamaica 2
KG - Kirghizistan 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.031
Salva come PNG Salva come JPEG
Città #
Chandler 298
Dublin 275
Jacksonville 215
Singapore 196
Nanjing 178
San Jose 178
Hong Kong 160
Ashburn 157
Beijing 131
Dallas 105
Boardman 78
Nanchang 70
Ann Arbor 59
Johannesburg 54
Los Angeles 52
Lawrence 49
Princeton 49
Council Bluffs 48
Wilmington 46
Hebei 45
Helsinki 43
Lauterbourg 43
Ho Chi Minh City 42
Jiaxing 40
Medford 40
New York 39
Shenyang 39
Changsha 38
Hanoi 33
Munich 30
Turku 29
Hangzhou 25
Buffalo 24
Moscow 24
Tianjin 24
Shanghai 20
Santa Clara 19
Brussels 14
Chennai 14
Des Moines 13
Redondo Beach 12
Seattle 12
Warsaw 12
Milan 11
Woodbridge 11
Da Nang 10
London 10
Guangzhou 9
Tokyo 9
Brno 8
Norwalk 8
Orem 8
San Francisco 8
Fairfield 7
Frankfurt am Main 7
Montreal 7
São Paulo 7
The Dalles 7
Atlanta 6
Boston 6
Brooklyn 6
Houston 6
Kunming 6
Pavia 6
Stockholm 6
Tashkent 6
Chicago 5
Haiphong 5
Quito 5
Santa Fe 5
St Petersburg 5
Toronto 5
Verona 5
Addis Ababa 4
Amsterdam 4
Mexico City 4
Salvador 4
San Genesio Ed Uniti 4
Stamford 4
The Bronx 4
Alexandria 3
Amman 3
Andover 3
Ankara 3
Belo Horizonte 3
Biên Hòa 3
Brasília 3
Cambridge 3
Carapicuíba 3
Falkenstein 3
Fes 3
Fortaleza 3
Haikou 3
Jinan 3
João Pessoa 3
Kuala Lumpur 3
Manchester 3
Mumbai 3
Ningbo 3
Nuremberg 3
Totale 3.370
Salva come PNG Salva come JPEG
Nome #
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 164
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system 146
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma 144
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 137
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 131
Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. 128
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 127
Bortezomib-induced paralytic ileus is a potential gastrointestinal side-effect of this first-in-class anti-cancer proteasome inhibitor 126
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 125
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. 124
International prognostic scoring system for Waldenstrom macroglobulinemia 123
Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (Intern Emerg Med, (2014), 9, (861-870), DOI 10.1007/s11739-014-1096-1) 121
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 118
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. 118
The prognosis of patients with liver metastases from colorectal cancer still depends on anatomical presentation more than on treatments 114
Improving the AJCC/TNM Classification for use in early gastric cancer 113
Basic and acidic isoferritins in the serum of patients with Hodgkin's disease. 110
Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study 110
Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? 110
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 109
R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL). 109
Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients 107
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 105
Chronic granulocytic leukemia. A retrospective study of 91 cases. I. Hemogram at diagnosis and research of prognostic factors. 105
How I treat enteropathy-associated T-cell lymphoma 104
International prognostic scoring system for Waldenstrom macroglobulinemia. 104
Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy. 103
Changing clinical presentation of multiple myeloma. 100
Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in- class anticancer proteasome inhibitor. 100
Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells 99
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 97
Tumor burden in Hodgkin’s lymphoma: much more than the best prognostic factor. 96
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. 95
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters 95
Hodgkin lymphoma. 95
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 93
What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma ? 92
Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi. 91
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. 86
Long-term follow-up analysis of HD9601 trial comparing ABVD vs. Stanford V vs. MOPPEBVCAD in patients with newly diagnosed advanced-stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (IIL). 86
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 86
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. 86
The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer 74
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia 72
Reed-Sternberg cell leukaemia. 70
Natural history of idiopathic refractory sideroblastic anemia. 63
Low incidence but poor prognosis of complicated coeliac disease in four Italian centres. 63
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility 62
Prognostic factors in non-Hodgkin's lymphomas 52
Totale 5.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 3 2 4 7 2 6 15 6 11 40 139
2022/2023790 76 76 9 67 81 76 2 56 316 6 16 9
2023/2024235 44 39 10 17 19 56 3 28 1 5 4 9
2024/2025682 33 51 20 16 25 19 39 32 178 19 80 170
2025/20261.661 100 82 166 200 221 60 321 99 147 143 53 69
2026/2027100 30 70 0 0 0 0 0 0 0 0 0 0
Totale 5.088